Literature DB >> 22101602

Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils.

Jan Bieschke1, Martin Herbst, Thomas Wiglenda, Ralf P Friedrich, Annett Boeddrich, Franziska Schiele, Daniela Kleckers, Juan Miguel Lopez del Amo, Björn A Grüning, Qinwen Wang, Michael R Schmidt, Rudi Lurz, Roger Anwyl, Sigrid Schnoegl, Marcus Fändrich, Ronald F Frank, Bernd Reif, Stefan Günther, Dominic M Walsh, Erich E Wanker.   

Abstract

Several lines of evidence indicate that prefibrillar assemblies of amyloid-β (Aβ) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of Aβ fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in Aβ peptides and stabilizes the self-assembly of seeding-competent, β-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic Aβ oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by Aβ oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101602     DOI: 10.1038/nchembio.719

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  48 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

Review 2.  Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease.

Authors:  T Hamaguchi; K Ono; M Yamada
Journal:  Cell Mol Life Sci       Date:  2006-07       Impact factor: 9.261

3.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.

Authors:  Dagmar E Ehrnhoefer; Martin Duennwald; Phoebe Markovic; Jennifer L Wacker; Sabine Engemann; Margaret Roark; Justin Legleiter; J Lawrence Marsh; Leslie M Thompson; Susan Lindquist; Paul J Muchowski; Erich E Wanker
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

4.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

5.  High-resolution atomic force microscopy of soluble Abeta42 oligomers.

Authors:  Iris A Mastrangelo; Mahiuddin Ahmed; Takeshi Sato; Wei Liu; Chengpu Wang; Paul Hough; Steven O Smith
Journal:  J Mol Biol       Date:  2006-01-30       Impact factor: 5.469

6.  Structural properties of Abeta protofibrils stabilized by a small molecule.

Authors:  Angela D Williams; Matt Sega; Maolian Chen; Indu Kheterpal; Merav Geva; Valerie Berthelier; David T Kaleta; Kelsey D Cook; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

Review 8.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

9.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

10.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

View more
  142 in total

1.  Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.

Authors:  Jennifer C Boatz; Talia Piretra; Alessia Lasorsa; Irina Matlahov; James F Conway; Patrick C A van der Wel
Journal:  J Mol Biol       Date:  2020-06-27       Impact factor: 5.469

2.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

3.  The C-terminal repeating units of CsgB direct bacterial functional amyloid nucleation.

Authors:  Neal D Hammer; Bryan A McGuffie; Yizhou Zhou; Matthew P Badtke; Ashley A Reinke; Kristoffer Brännström; Jason E Gestwicki; Anders Olofsson; Fredrik Almqvist; Matthew R Chapman
Journal:  J Mol Biol       Date:  2012-06-07       Impact factor: 5.469

Review 4.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

5.  What Can the Kinetics of Amyloid Fibril Formation Tell about Off-pathway Aggregation?

Authors:  Rosa Crespo; Eva Villar-Alvarez; Pablo Taboada; Fernando A Rocha; Ana M Damas; Pedro M Martins
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

6.  Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42.

Authors:  Man Hoang Viet; Phuong H Nguyen; Son Tung Ngo; Mai Suan Li; Philippe Derreumaux
Journal:  ACS Chem Neurosci       Date:  2013-09-16       Impact factor: 4.418

Review 7.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

8.  Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.

Authors:  Xinwei Ge; Yunxiang Sun; Feng Ding
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-14       Impact factor: 3.747

9.  Nanoscale inhibition of polymorphic and ambidextrous IAPP amyloid aggregation with small molecules.

Authors:  Aleksandr Kakinen; Jozef Adamcik; Bo Wang; Xinwei Ge; Raffaele Mezzenga; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Nano Res       Date:  2018-08-02       Impact factor: 8.897

10.  Heparin nanoparticles for β amyloid binding and mitigation of β amyloid associated cytotoxicity.

Authors:  Peng Wang; Hovig Kouyoumdjian; David C Zhu; Xuefei Huang
Journal:  Carbohydr Res       Date:  2014-08-02       Impact factor: 2.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.